Genomic Profiling of Smoldering Multiple Myeloma Identifies ...

SMM is a genetically mature entity whereby most driver genetic alterations have already occurred, which suggests the existence of a ...

We identified and externally validated genomic predictors of progression that could distinguish patients at high risk of progression to MM.

The genomic profiling of high-risk smoldering myeloma patients ...

Smoldering multiple myeloma (SMM) precedes multiple myeloma (MM). The risk of progression of SMM patients is not uniform, thus different ...

Genomic profiling of smoldering multiple myeloma identifies patients ...

Conclusion. Genomic profiling of SMM patients can identify high-risk group of patients that can go undetected by purely clinical risk models leading to improved ...

Abstract 2240: Genomic profiling of smoldering multiple myeloma ...

It is usually preceded by the asymptomatic stage known as smoldering multiple myeloma (SMM). SMM patients have a 10% annual risk of progression ...

Genomic profiling of smoldering multiple myeloma identifies patients ...

Genomic profiling of SMM patients can identify high-risk group of patients that can go undetected by purely clinical risk models leading to improved efficiency ...

The genomic profiling of high-risk smoldering myeloma patients ...

Smoldering multiple myeloma (SMM) precedes multiple myeloma (MM) ... identifying genomic predictors of poor outcomes in this setting.

1 Genomic profiling of smoldering multiple myeloma identifies ...

Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression. Mark Bustoros1,2,3*, Romanos Sklavenitis ...

Genomic profiling of smoldering multiple myeloma identifies patients ...

Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression. / Bustoros, Mark; Sklavenitis-Pistofidis, Romanos; ...

Genomic profiling of smoldering myeloma identifies high- and low

In this video, Shankara Anand, MS, Broad Institute of MIT & Harvard, Cambridge, MA, discusses genomic profiling of smoldering multiple ...

Latest Medical Findings - Genomic Profiling and Smoldering Myeloma

Advanced genome sequencing when a person has smoldering myeloma (or SMM) can help identify which patients are at higher risk of progression to MM. Identified ...

Genomic Profiling of Smoldering Multiple Myeloma Classifies ...

Our results underscore the importance of molecular classification in addition to clinical evaluation in better identifying high-risk SMM ...

Genomic Profiling to Contextualize the Results of Intervention for ...

On the spectrum of precursor conditions is smoldering multiple myeloma (SMM), a clinically defined state of asymptomatic expansion of clonal plasma cells for ...

Genomic profiling of smoldering multiple myeloma identifies patients ...

Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression · Overview · Fingerprint ...

Genomic Profiling of Smoldering Multiple Myeloma Identifies ...

Request PDF | Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression | PURPOSE Smoldering multiple ...

The 3D- Telomere Profiling Assay Identifies High Risk Smoldering ...

Smoldering multiple myeloma (SMM) is an asymptomatic precursor stage of multiple myeloma (MM). According to the international Myeloma ...

Genomic Profiling of Smoldering Multiple Myeloma Identifies ...

PURPOSESmoldering multiple myeloma (SMM) is a precursor condition of multiple myeloma (MM) with a 10% annual risk of progression.

Genetic subtypes of smoldering multiple myeloma are associated ...

Smoldering multiple myeloma (SMM) is a precursor condition of multiple myeloma (MM) with significant heterogeneity in disease progression.

Genomic profiling of treated high-risk smoldering multiple myeloma

Benjamin Diamond, MD, Sylvester Comprehensive Cancer Center, Miami, FL, discusses a study which used whole-genome and whole-exome sequencing ...

Genomic Profiling of Smoldering Multiple Myeloma Classifies ...

The predicted clinical outcomes for the molecular subtypes were further validated in an independent SMM cohort of 74 patients. Results: We identified six ...